Viatris Inc

Financials

Overview Отчетность Statistics Dividends

Cash from operating activities 1.23 B3.02 B2.95 B2.8 B2.3 B2.32 B 2.32 B Cash from investing activities 301.1 M117.8 M1.52 B764.1 M1.8 B427.7 M 427.7 M Cash from financing activities 605.7 M3.01 B3.88 B2.3 B4.33 B1.29 B 1.29 B Free cash flow 988.8 M2.56 B2.55 B2.42 B1.98 B1.94 B 1.94 B

Viatris Inc. is an American global pharmaceutical and healthcare corporation headquartered in Canonsburg, Pennsylvania. The corporation was formed through the merger of Mylan and Upjohn, a legacy division of Pfizer, on November 16, 2020. The name of the corporation comes from the Latin words via, meaning path, and tris, which means three, referring to the path to three main objectives the corporation set: expanding access to medicines, meeting patient needs through innovation, and earning the trust of the healthcare community. Viatris ranked 254th on the 2021 Fortune 500 rankings of the largest United States corporations based on its 2020 total revenue.

VTRS

Financials

Viatris Inc

Новости

IHE: U.S. Pharmaceuticals ETF With Excellent GARP Features (NYSEARCA:IHE)

UBS повысил целевую цену акций Viatris до $20

UBS raises Viatris stock price target to $20 on cost savings

BofA повышает целевую цену акций Viatris на фоне плана сокращения затрат

BofA raises Viatris stock price target on cost-cutting plan

Viatris Q4 EPS Tops, Brands Drive Revenue Growth, Stock Up

Viatris Q4 2025: прибыль превысила прогнозы, план сокращения затрат

Viatris Q4 2025 slides: earnings beat, major cost-cutting plan

Viatris (VTRS) Surpasses Q4 Earnings and Revenue Estimates

Viatris Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:VTRS) 2026-02-26

Акции Viatris падают из-за прогноза прибыли на 2026 год

Viatris shares fall on lower-than-expected 2026 profit outlook